EVIDENCE. COMPARISONS. CLEAR NEXT STEPS.FOR US CLINIC TEAMS PROCUREMENT RESEARCH
Direct questions

26. Who should own prior authorization and patient-access work?

Dose Diligence research deskSection 01 · Page 26 of 34Last updated 17 Nov 2026

Assign an accountable owner for each step; do not assume the pharmacy, clinic or manufacturer programme performs the entire process. Price the clinic’s remaining workload explicitly.

ASHP’s medication-access coordinator template includes benefits investigation, authorization submissions, status tracking and escalation of denials or nonresponse. A November 12, 2026 Optum job posting similarly identifies authorization, benefit review and financial-assistance work. These sources illustrate functions—not a staffing ratio for GLP-1 clinics. (ashp.org)

Use a responsibility matrix covering:

  • Benefits verification and route selection.
  • Clinical documentation and clinician attestation.
  • Submission and follow-up.
  • Denial review and appeal decisions.
  • Patient communication and alternative-access discussion.
  • Reauthorization and coverage changes.

Measure handling minutes by case type. A clean cash transaction, a commercial denial and a Medicare Bridge request should not receive one assumed labour cost.

Avoid committing to patient turnaround promises before measuring the handoffs outside your control.

Sources cited on this page

  1. ashp.org · Source 1 ↗https://www.ashp.org/-/media/assets/pharmacy-practice/resource-centers/specialty-pharmacy/Medication-Access-Coordinator.pdf
Section sources →